Les psychédéliques, traitements du futur | Lucie Berkovitch | TEDxAgroParisTech
Psychiatrist Lucie Berkovitch presents research on psychedelics as promising psychiatric treatments, explaining their history, mechanisms of action in the brain, therapeutic applications for depression and addiction, and the challenges of implementing them in clinical practice.
Summary
Dr. Lucie Berkovitch, a psychiatrist and cognitive neuroscience researcher at Saint-Anne Hospital in Paris, delivers a comprehensive overview of psychedelics and their therapeutic potential. She begins by distinguishing psychedelics from popular cultural stereotypes, defining them as substances that trigger unique psychological experiences. The transcript covers four primary psychedelic substances: ayahuasca, LSD, psilocybin mushrooms, and mescaline, all of which can be synthesized in laboratories.
Berkovitch provides historical context, explaining that psychedelics were used ritually for millennia before arriving in the West in the late 19th century. A pivotal moment occurred in 1943 when Swiss chemist Albert Hoffman accidentally discovered LSD while working on ergot derivatives, likely through improper hand hygiene and subsequent eye contact. Initially, psychiatrists self-experimented with psychedelics to understand hallucinations experienced by schizophrenic patients. Early therapeutic studies showed mixed results, and the counterculture movement of the 1960s led to widespread use and subsequent government bans in 1970, halting legitimate research for two decades.
Research resumed in the 1990s with advances in brain imaging technology. Berkovitch then discusses ketamine, an anesthetic with rapid antidepressant effects discovered around 2000, which revolutionized acute psychiatric care but requires repeated administration and doesn't provide lasting effects. This contrasts with psychedelics, which demonstrate both immediate and sustained therapeutic benefits.
The speaker presents clinical evidence showing psychedelics' efficacy: studies from 2010 onward demonstrated that psilocybin and LSD reduced anxiety by 60% in palliative care patients; 30-50% of depression patients achieved remission lasting weeks to months; and 60-80% of tobacco users quit permanently after psychedelic-assisted therapy, with alcohol-dependent patients reducing consumption by five-fold. Psychedelics are always administered alongside psychotherapy, which serves dual purposes: ensuring safety and potentiating therapeutic benefits.
Berkovitch explains the neurological mechanisms through brain imaging studies. Psychedelics activate the 5HT2A serotonin receptor, causing desynchronization and apparent "anarchy" of brain activity. This results in increased sensory processing, enhanced positive emotion sensitivity while reducing negative emotion reactivity, decreased self-focused rumination, and altered predictive brain functions. Critically, neurons physically grow and form new connections during and after the experience, enabling lasting brain reconfiguration that psychotherapy can leverage.
The speaker addresses safety concerns directly, noting that scientific studies have documented no cases of severe decompensation, persistent psychosis, or addiction to psychedelics themselves. The benefit-risk ratio appears exceptionally favorable compared to conventional treatments. However, psychedelics remain unavailable in routine French medical care and are only accessible through experimental research protocols at specialized hospitals like Saint-Anne.
Berkovitch concludes by acknowledging the challenges of implementing psychedelics in underfunded public hospital systems that currently operate under severe resource constraints, emphasizing that research progress requires collective effort, political support, and concrete financial investment alongside rigorous scientific methodology.
Key Insights
- Albert Hoffman discovered LSD accidentally in 1943 likely through improper hand hygiene while working on ergot derivatives, and then self-experimented with 250 micrograms, an extremely high dose, demonstrating that accidental discoveries sometimes require courage and risk-taking to validate
- Psychedelics demonstrate both immediate antidepressant effects and lasting therapeutic benefits lasting weeks to months, with 30-50% of depression patients achieving full remission, making them fundamentally different from ketamine which requires repeated doses and doesn't produce sustained effects
- Psychedelics activate the 5HT2A serotonin receptor causing brain desynchronization, decreased self-rumination activity, increased positive emotion sensitivity, and physically lasting neuronal growth and new connections that persist days and weeks after administration
- No serious adverse effects, schizophrenia development, or addiction to psychedelics have been documented across scientific studies, and psychedelics actually help break addiction to other substances, establishing an exceptionally favorable benefit-risk ratio compared to conventional psychiatric medications
- Despite favorable evidence, psychedelics remain unavailable in routine French medical care and can only be accessed through experimental research protocols, with implementation in underfunded public hospitals presenting major challenges requiring political support and substantial financial investment
Topics
Transcript
[0:02] [applause] [applause] Good evening. So tonight, I'm going to talk to you about psychedelia. So maybe when we say psychedelic, you imagine this or even this. And what I'm going to talk to you about is this . A set of substances which, when consumed, trigger a unique experience known as the psychedelic experience. So what you see [0:32] on this table is, in the upper left, a glass of ayawaska, a beverage that is obtained from a vine. In the upper right corner, a strip of LSD blotter paper. Bottom left , hallucinogenic mushrooms that contain psilocybin and bottom right a small flowering cactus from which mescaline can be extracted. All these substances can be manufactured in the…
Full transcript available for MurmurCast members
Sign Up to AccessMore from TEDx Talks
Literature, Meaning, and the Modern World | Raaz Ahtesham | TEDxFASTIslamabad
Raaz Ahtesham, a poet and software engineer, discusses meta-writing in post-modern literature and its relevance to contemporary society. He explores how literature reflects deeper truths through self-referential techniques and argues that Eastern societies must understand their own foundational issues rather than merely copying Western philosophical approaches.
Community in modern Malta | Sasha Vella | TEDxUniversityofMalta
Sasha Vella contrasts the strong community bonds she experienced in rural Gozo with the individualism-driven disconnection prevalent in modern Malta, arguing that while individualism has brought freedom and innovation, unchecked pursuit of personal success without community consciousness leads to isolation, loss of empathy, and societies that merely function rather than truly thrive.
The Price of War | Filip Dikmen | TEDxMalmö
Filip Dikmen examines the patriarchy as a system that demands violence and sacrifice from men rather than only oppressing women. He traces three historical grooming techniques—separation from the feminine, public humiliation, and sexual rewards—and explores how these patterns persist today, creating cycles of trauma that damage families and societies while serving the interests of those in power.
Community Filmmaking Leads to Empowerment | Zan Azlee | TEDxUTM
Zan Azlee, a journalist and documentary filmmaker, transitioned from parachute journalism covering war zones to community filmmaking with the Bajau people in Sabah. By teaching indigenous youth video production skills and empowering them to tell their own stories, he demonstrated how storytelling can create economic opportunities and social empowerment for marginalized communities.
Think Big | Arumugam Sakthivel | TEDxKids Club CBSE School
Arumugam Sakthivel shares his entrepreneurial journey from starting with 50,000 rupees to building a 1,500+ crore business group, emphasizing the importance of 'thinking big.' He discusses overcoming an 85-lakh debt crisis, expanding into exports, and leveraging his success to drive infrastructure and social development in Tiruppur through the Tiruppur Exporters Association.